Bradley D. Page - 18 Jan 2024 Form 4 Insider Report for Physicians Realty Trust

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 Jan 2024, 16:56:32 UTC
Prior SEC filing
03 Mar 2023
Next SEC filing
01 Mar 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christopher M. Bartoli, as attorney-in-fact

Key filing fact

Bradley D. Page filed Form 4 for Physicians Realty Trust on 22 Jan 2024.

Key facts

  • This page summarizes Bradley D. Page's Form 4 filing for Physicians Realty Trust.
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 22 Jan 2024, 16:56.

Change

  • Previous filing in this sequence was filed on 03 Mar 2023.
  • Current net transaction value: -$234,188.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DOC transaction

Common shares, $0.01 par value

Options Exercise

Transaction value
Shares
+37,221
Change %
+234%
Price
Shares after
53,126
Date
18 Jan 2024
Ownership
Direct
Footnotes
F1, F2
DOC transaction

Common shares, $0.01 par value

Tax liability

Transaction value
$234,188
Shares
-18,084
Change %
-34%
Price
$12.95
Shares after
35,042
Date
18 Jan 2024
Ownership
Direct
DOC holding

Common shares, $0.01 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
131,189
Date
18 Jan 2024
Ownership
Represents shares held by the Bradley D. Page and Cheryl M. Page Joint Revocable Trust Dated 1/19/15
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DOC transaction Derivative

2021 Performance Based Restricted Share Unit Grant

Options Exercise

Transaction value
$0
Shares
-18,722
Change %
-100%
Price
$0.000000*
Shares after
0
Date
18 Jan 2024
Ownership
Direct
Underlying class
Common shares, $0.01 par value
Underlying amount
18,722
Exercise price
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents vesting of the 2021 Performance Based Restricted Share Units granted on March 1, 2021 under the Issuer's Equity Incentive Plan (the "Plan"). Subject to the terms of the grant, the Reporting Person received 37,221 common shares upon vesting.

Footnote F2

Includes 1,627 shares and 110 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on June 30, 2023 and December 29, 2023, respectively, and a transfer of 34,866 shares to the Bradley D. Page and Cheryl M. Page Joint Revocable Trust Dated January 19, 2015.

Footnote F3

Includes a transfer of 34,866 shares from the Reporting Person.

Footnote F4

On March 1, 2021, the Reporting Person was granted 18,722 performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. Subject to the terms of the grant, the Reporting Person received 37,221 common shares upon vesting.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .